Literature DB >> 10081978

Alterations in neurokinin A-, substance P- and calcitonin gene-related peptide immunoreactivities in the caudal trigeminal nucleus of the rat following electrical stimulation of the trigeminal ganglion.

M Samsam1, R Coveñas, R Ahangari, J Yajeya, J A Narváez, G Tramu.   

Abstract

We have carried out an immunohistochemical study on the presence of neurokinin A (NKA) and substance P (SP) in the rat caudal trigeminal nucleus (CTN) after electrical stimulation of the trigeminal ganglion (TG), used as an experimental model to induce alterations, some of which may occur during migraine attacks (release of vasoactive peptides from perivascular trigeminal axons and neurogenic inflammation). Both unilateral, 30 min electrical stimulation (5 Hz, 5 ms, 0.1-1 mA) of the TG and 5 min stimulation with a slight increase in the stimulating parameters (7.5 Hz, 5 ms, 1.4 mA) caused a significant depletion of the NKA and SP immunoreactivities (-IR) of the TG nerve central terminals in the ipsilateral CTN. Calcitonin gene-related peptide (CGRP)-IR of the ipsilateral CTN was also studied in the CTN using the increased stimulating parameters and a marked depletion of CGRP-IR was also observed following TG stimulation. Such depletion may be due to the release of neuropeptides from the trigeminal central terminals. These findings suggest that NKA, SP and CGRP could act as neurotransmitters at the first central synapses of the trigeminal nociceptive pathway to transmit the sensory stimuli to the higher brain centers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081978     DOI: 10.1016/s0304-3940(98)00989-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

2.  Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.

Authors:  Zsuzsanna Bohár; Gábor Nagy-Grócz; Annamária Fejes-Szabó; Lilla Tar; Anna M László; Alexandra Büki; Nikolett Szabadi; Veronika Vraukó; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575

3.  Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain.

Authors:  Philippe Luccarini; Mélaine Henry; Pedro Alvarez; Anne-Marie Gaydier; Radhouane Dallel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-27       Impact factor: 3.000

4.  Evaluation of c-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion.

Authors:  Zsuzsanna Bohár; Annamária Fejes-Szabó; Lilla Tar; Hedvig Varga; János Tajti; Árpád Párdutz; László Vécsei
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

5.  Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate.

Authors:  Charlotte Kageneck; Barbara E Nixdorf-Bergweiler; Karl Messlinger; Michael Jm Fischer
Journal:  J Headache Pain       Date:  2014-02-08       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.